ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 392 filers reported holding ASTRAZENECA PLC in Q4 2014. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,685,282 | +46.2% | 21,609 | +27.0% | 0.04% | +34.6% |
Q1 2024 | $1,152,503 | +23.9% | 17,011 | +23.2% | 0.03% | +13.0% |
Q4 2023 | $930,370 | +46.9% | 13,813 | +47.7% | 0.02% | +35.3% |
Q3 2023 | $633,481 | -4.0% | 9,354 | +1.4% | 0.02% | -5.6% |
Q2 2023 | $660,104 | -33.3% | 9,224 | -35.3% | 0.02% | -33.3% |
Q1 2023 | $989,138 | +0.9% | 14,251 | -1.5% | 0.03% | -10.0% |
Q4 2022 | $980,594 | +12.3% | 14,463 | -9.1% | 0.03% | -3.2% |
Q3 2022 | $873,000 | -13.0% | 15,911 | +4.6% | 0.03% | -8.8% |
Q2 2022 | $1,004,000 | +64.9% | 15,215 | +65.9% | 0.03% | +88.9% |
Q1 2022 | $609,000 | +63.3% | 9,173 | +43.1% | 0.02% | +63.6% |
Q4 2021 | $373,000 | -20.1% | 6,411 | -17.5% | 0.01% | -26.7% |
Q3 2021 | $467,000 | +15.3% | 7,771 | +14.9% | 0.02% | +15.4% |
Q2 2021 | $405,000 | +13.1% | 6,765 | -6.2% | 0.01% | 0.0% |
Q1 2021 | $358,000 | -45.8% | 7,210 | -45.5% | 0.01% | -51.9% |
Q4 2020 | $661,000 | +25.7% | 13,229 | +37.8% | 0.03% | +8.0% |
Q3 2020 | $526,000 | +19.0% | 9,597 | +14.9% | 0.02% | +4.2% |
Q2 2020 | $442,000 | +40.3% | 8,350 | +18.4% | 0.02% | +14.3% |
Q1 2020 | $315,000 | -18.0% | 7,052 | -8.6% | 0.02% | +5.0% |
Q4 2019 | $384,000 | +46.0% | 7,712 | +21.0% | 0.02% | +25.0% |
Q3 2019 | $263,000 | 0.0% | 6,373 | 0.0% | 0.02% | 0.0% |
Q2 2019 | $263,000 | +7.8% | 6,373 | +5.6% | 0.02% | -5.9% |
Q1 2019 | $244,000 | -3.6% | 6,036 | -9.4% | 0.02% | -22.7% |
Q4 2018 | $253,000 | +5.0% | 6,659 | +9.4% | 0.02% | +22.2% |
Q3 2018 | $241,000 | -4.0% | 6,089 | -7.3% | 0.02% | -5.3% |
Q2 2018 | $251,000 | -2.0% | 6,568 | -10.3% | 0.02% | -5.0% |
Q1 2018 | $256,000 | +16.9% | 7,319 | +15.8% | 0.02% | +5.3% |
Q4 2017 | $219,000 | +67.2% | 6,319 | +64.0% | 0.02% | +26.7% |
Q3 2017 | $131,000 | +28.4% | 3,854 | +28.8% | 0.02% | +15.4% |
Q2 2017 | $102,000 | +6.2% | 2,993 | -2.7% | 0.01% | -7.1% |
Q1 2017 | $96,000 | +190.9% | 3,077 | +203.2% | 0.01% | +133.3% |
Q3 2016 | $33,000 | +266.7% | 1,015 | +233.9% | 0.01% | +200.0% |
Q2 2016 | $9,000 | 0.0% | 304 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $9,000 | -30.8% | 304 | -19.6% | 0.00% | -50.0% |
Q4 2015 | $13,000 | +8.3% | 378 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $12,000 | +33.3% | 378 | +186.4% | 0.00% | +33.3% |
Q2 2015 | $9,000 | 0.0% | 132 | 0.0% | 0.00% | +50.0% |
Q1 2015 | $9,000 | 0.0% | 132 | 0.0% | 0.00% | -33.3% |
Q4 2014 | $9,000 | -92.2% | 132 | -93.2% | 0.00% | -94.8% |
Q4 2013 | $116,000 | – | 1,948 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |